Analysts say Beijing's concern might be that approval of the BioNTech shot could be interpreted as an acknowledgment that local shots are less effective than western ones.
Researchers noted that antibody concentrations for BioNTech recipients rose 'substantially' after first dose, but Sinovac recipients showed 'low' level of antibodies after first shot.
Study finds Pfizer-BioNTech vaccine has favourable safety profile in 12-15-year-olds, produces greater immune response than in young adults, is highly effective against Covid-19.
A group of advisers to Centers for Disease Control and Prevention will meet Wednesday to make recommendations for administering the vaccine. Kids could begin receiving them Thursday.
While the research, performed by University of Texas Medical Branch in Galveston, needs to be validated with real-world data, it offers another reason for optimism.
Two doses prevented 94% of Covid-19 cases in 596,618 people vaccinated between 20 Dec and 1 Feb, teams from Clalit Research Institute and Harvard University reported in a study.
The results published Wednesday showed that antibodies in the blood of people who had been vaccinated were able to neutralize a version of the mutant virus that was created in the lab.
IAF is firming up plans to revamp airlift capabilities with medium transport aircraft that will be assembled in India & serve as its main workhorse. Embraer is leading contender as of now.
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.
COMMENTS